Exosla Therapeutics
Pre-clinicalYour browser does not support HTML5 video. Greatly improving neurological outcomes for newborn infants Pioneering immune-modulatory, off-the-shelf restorative medicine Science Multimodal signalling approaches are the future of immunotherapy, ranging from autoimmunity to tissue repair. However, they have been hindered by various scientific and manufacturing challenges, such as lack of adequate quality control and batch-to-batch
About
Your browser does not support HTML5 video. Greatly improving neurological outcomes for newborn infants Pioneering immune-modulatory, off-the-shelf restorative medicine Science Multimodal signalling approaches are the future of immunotherapy, ranging from autoimmunity to tissue repair. However, they have been hindered by various scientific and manufacturing challenges, such as lack of adequate quality control and batch-to-batch
Funding History
1Total raised: $4.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile